Plants’ New Frontier as Molecular Farming Biofactories

This article explores how biotechnology is transforming plants into “biofactories” through molecular farming—engineering crops to produce animal proteins and pharmaceutical compounds. Instead of relying on animals, cell cultures, or energy-intensive bioreactors, companies are using plants like rice, soy, potatoes, and oats to grow proteins such as casein for dairy, egg proteins, and even therapeutic drugs. The promise is lower cost, lower environmental impact, and easier scaling, since production can resemble traditional agriculture. The piece shows how dairy is leading the way, with startups aiming to solve the biggest weakness of plant-based cheese by adding real milk proteins grown in plants. It also highlights regulatory and consumer hurdles, including allergen concerns and differing rules across regions. Beyond food, the article points to early successes in “biopharming,” where plants may one day produce medicines more affordably and safely. Overall, it frames molecular farming as a platform technology poised to reshape food, medicine, and manufacturing—potentially making plants central to how we produce both nutrition and therapeutics.